Received Jun 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y49BZ | — |
20 month old that received Kinrix; Incorrect vaccine/the patient needed the Dtap/IPV immunization; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 20-month-old patient who received DTPa-IPV (Kinrix) (batch number Y49BZ, expiry date 17-MAY-2026) for prophylaxis. Co-suspect products included DTPa-IPV (DTPa-IPV) for prophylaxis. On an unknown date, the patient received Kinrix and DTPa-IPV. On an unknown date, an unknown time after receiving Kinrix and not applicable after receiving DTPa-IPV, the patient experienced inappropriate age at vaccine administration (Verbatim: 20 month old that received Kinrix) and wrong vaccine administered (Verbatim: Incorrect vaccine/the patient needed the Dtap/IPV immunization). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUN-2025 The nurse reported that they had a 20-month-old patient that received Kinrix which led to inappropriate age at vaccine administration, and he/she was asked to follow-up if there is any concern or anything that need to be done. When asked what vaccine was supposed to receive, the nurse answered that the patient needed the Dtap/IPV immunization for the patient's age which led to wrong vaccine administered.